Skip to main content

Post-Heparin Lipolytic Activities in Chronic Renal Failure Patients in Relation to Plasma Triglycerides

  • Chapter
  • 93 Accesses

Part of the book series: NATO ASI Series ((NSSA,volume 266))

Abstract

Chronic renal failure (CRF) is responsible for several abnormalities of lipoprotein metabolism and represents an increased risk of atherosclerosis [1,2]. Hypertriglyceridemia is very often observed in patients suffering from terminal CRF, treated by hemodialysis or not, while plasma cholesterol is either normal or slightly elevated. Among the numerous risk factors presented by uremic patients, it is not easy to know precisely the role of hypertriglyceridemia. The general increase in all the triglyceride-rich lipoproteins is a consequence of their impaired metabolism.

This is a preview of subscription content, log in via an institution.

Buying options

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   169.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   219.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

References

  1. Appel, G., Lipid abnormalities in renal disease, Kidney Int. 39 (1991) 169–183.

    Article  PubMed  CAS  Google Scholar 

  2. Attman, P., and Alaupovic, P., Lipid and apolipoprotein profiles of uremic dyslipoproteinemia: relation to renal function and dialysis, Nephron 57 (1991) 401410.

    Google Scholar 

  3. Taskinen, M.R., Lipoprotein lipase in hypertriglyceridemias, in: “Lipoprotein lipase,” J. Borensztajn, ed., Evener Publishers, Chicago (1987) pp 201–227.

    Google Scholar 

  4. Simard, G., and Perret, B., La triglycéride lipase hépatique, Ann. Biol. Clin. 48 (1990) 61–76.

    CAS  Google Scholar 

  5. Attman, P., Gustafon, A., and Alaupovic, P., Lipid metabolism in patients with chronic renal failure in the predialytic phase, Contr. Nephrol. 65 (1988) 24–32.

    CAS  Google Scholar 

  6. Shoji, T., Nishizawa, Y., Nishitani, H., et al., Impaired metabolism of high density lipoprotein in uremic patients, Kidney Int. 41 (1992) 653–1661.

    Article  Google Scholar 

  7. Fruchart, J.C., Du cholestérol aux particules lipoprotéiques marqueurs et/ou facteurs de risque, Bull. Acad. Natle. Méd. 175 (1991) 51–65.

    CAS  Google Scholar 

  8. Nilsson-Ehle, P., Measurements of lipoprotein lipase activity, in: “Lipoprotein lipase,” J. Borensztajn, ed., Evener Publishers, Chicago (1987) pp 59–77.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1994 Springer Science+Business Media New York

About this chapter

Cite this chapter

Abdallah, A., Pascual de Zulueta, M., Richard, P., Higueret, D., Cassaigne, A., Iron, A. (1994). Post-Heparin Lipolytic Activities in Chronic Renal Failure Patients in Relation to Plasma Triglycerides. In: Mackness, M.I., Clerc, M. (eds) Esterases, Lipases, and Phospholipases. NATO ASI Series, vol 266. Springer, Boston, MA. https://doi.org/10.1007/978-1-4899-0993-0_22

Download citation

  • DOI: https://doi.org/10.1007/978-1-4899-0993-0_22

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4899-0995-4

  • Online ISBN: 978-1-4899-0993-0

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics